BELNUC Technology Partner 2021
BELNUC is honored to present its technology partner for 2021: Advanced Accelerator Applications (AAA). AAA is an innovative medicines company focused on the development of products for targeted radioligand therapy and precision radioligand imaging. With the commitment of AAA, BELNUC is able to support its online educational activities and maintain its digital infrastructure.
Open call board member
The BELNUC Board hereby gives notice that the following BELNUC Board positions are open for election at the upcoming General Assembly, which will be held on March 6th 2021: One board member 2021-2023 (physician or physicist) We welcome all applications before February 5th 2021 online!
Winter School Dosimetry-Guided Treatment Planning for Radionuclide Therapy
January 20-22, 2021 (HS Maurice E. Müller, Inselspital, Bern, Switzerland) This Dosimetry School targets medical physicists, physicians, technologists and researchers involved and interested in the workflow of clinical dosimetry in support to personalized radionuclide therapy.
Tech Days ’20 Virtual Program and Flyer available
The final program and flyer for the Tech Days ’20 Virtual are now available! Read more: www.belnuc.be/tech-days-20-virtual Download the flyer
Event Tip: Winter School “Dosimetry Guided Treatment Planning for Radionuclide Therapy”
The dosimetry winter school takes place from March 04 to March 06, 2020 in Bern, Switzerland
Integrating PET imaging in drug development: a market model for PET imaging
April 4, 2019 | 09:00 – 17:00 Auditorium TI.K Vrije Universiteit Brussel Faculty GF – Building K Laarbeeklaan 103 1090 Brussels Download the program! Deadline for registration: March 8 Email: firstname.lastname@example.org
In memoriam Prof. Dr. Michel De Roo
With great sadness we inform you of the passing away of em. Prof. Dr. Michel De Roo on 13th February 2019. Michel De Roo was born in Leuven on 18th March 1931. In 1955 he obtained his doctorate in medicine. During his studies he came into contact with radiobiology in the context of radiation therapy […]